Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis.

Documenti analoghi

• MULTICENTRE DOUBLE-BLIND STUDY OF EFFECT OF INTRATHECALLY ADMINISTERED NATURAL HUMAN FIBROBLAST INTERFERON ON EXACERBATIONS OF MULTIPLE SCLEROSIS()
  di: Jacobs, Lawrence, et al.
  Pubblicazione: (1986)
• Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
  di: Lauria, Giuseppe, et al.
  Pubblicazione: (2015)
• MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
  di: Tourbah, Ayman, et al.
  Pubblicazione: (2016)
• Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.
  di: Belch, J J, et al.
  Pubblicazione: (1995)
• A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
  di: Collins, R C, et al.
  Pubblicazione: (1978)